These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8781586)

  • 1. Monitoring of occupational exposure to cytostatic anticancer agents.
    Sorsa M; Anderson D
    Mutat Res; 1996 Aug; 355(1-2):253-61. PubMed ID: 8781586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.
    Sessink PJ; Bos RP
    Drug Saf; 1999 Apr; 20(4):347-59. PubMed ID: 10230582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational exposure to anticancer drug--potential and real hazards.
    Sorsa M; Hemminki K; Vainio H
    Mutat Res; 1985 Sep; 154(2):135-49. PubMed ID: 3929080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handling anticancer drugs: from hazard identification to risk management?
    Sorsa M; Hämeilä M; Järviluoma E
    Ann N Y Acad Sci; 2006 Sep; 1076():628-34. PubMed ID: 17119240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.
    Moretti M; Bonfiglioli R; Feretti D; Pavanello S; Mussi F; Grollino MG; Villarini M; Barbieri A; Ceretti E; Carrieri M; Buschini A; Appolloni M; Dominici L; Sabatini L; Gelatti U; Bartolucci GB; Poli P; Stronati L; Mastrangelo G; Monarca S
    BMC Public Health; 2011 Mar; 11():195. PubMed ID: 21450074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals.
    Sorsa M; Pyy L; Salomaa S; Nylund L; Yager JW
    Mutat Res; 1988 Mar; 204(3):465-79. PubMed ID: 3347217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring occupational exposure to cancer chemotherapy drugs.
    Baker ES; Connor TH
    Am J Health Syst Pharm; 1996 Nov; 53(22):2713-23. PubMed ID: 8931813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaporation of selected cytotoxic drugs and permeation of protective gloves--research into the occupational risks of health care personnel handling hazardous cytotoxic drugs (CYTO project)].
    Dolezalová L; Odráska P; Gorná L; Prudilová M; Vejpustková R; Bláha L
    Klin Onkol; 2009; 22(5):218-22. PubMed ID: 19886359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomonitoring of occupational exposures to cytostatic anticancer drugs.
    Bos RP; Sessink PJ
    Rev Environ Health; 1997; 12(1):43-58. PubMed ID: 9128910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach.
    Kopjar N; Garaj-Vrhovac V; Kasuba V; Rozgaj R; Ramić S; Pavlica V; Zeljezić D
    Int J Hyg Environ Health; 2009 Jul; 212(4):414-31. PubMed ID: 19049854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomonitoring human exposure to environmental carcinogenic chemicals.
    Farmer PB; Sepai O; Lawrence R; Autrup H; Sabro Nielsen P; Vestergård AB; Waters R; Leuratti C; Jones NJ; Stone J; Baan RA; van Delft JH; Steenwinkel MJ; Kyrtopoulos SA; Souliotis VL; Theodorakopoulos N; Bacalis NC; Natarajan AT; Tates AD; Haugen A; Andreassen A; Ovrebø S; Shuker DE; Amaning KS; Castelain P
    Mutagenesis; 1996 Jul; 11(4):363-81. PubMed ID: 8671761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs.
    Kibby T
    J Occup Environ Hyg; 2017 Mar; 14(3):159-174. PubMed ID: 27676216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occupational exposure to antineoplastic drugs in a hospital setting: biological and environmental monitoring].
    Barbieri A; Nucci MC; Sabatini L; Risi A; Bolognesi C; Colacci A; Violante FS
    Epidemiol Prev; 2005; 29(5-6 Suppl):87-90. PubMed ID: 16646269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies.
    Ensslin AS; Huber R; Pethran A; Römmelt H; Schierl R; Kulka U; Fruhmann G
    Int Arch Occup Environ Health; 1997; 70(3):205-8. PubMed ID: 9298404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytostatic drugs: occupational hazard to health care workers].
    Andrzejak R; Kucharski W; Mioduszewska J
    Med Pr; 1999; 50(1):61-5. PubMed ID: 10399719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies.
    Schierl R; Böhlandt A; Nowak D
    Ann Occup Hyg; 2009 Oct; 53(7):703-11. PubMed ID: 19620232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP monograph on the systematic review of occupational exposure to cancer chemotherapy agents and adverse health outcomes.
    National Toxicology Program
    NTP Monogr; 2019 Mar; (5):. PubMed ID: 33556047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.
    Hedmer M; Wohlfart G
    J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.